Related Experiment Videos
Skin barrier function, epidermal proliferation and differentiation in eczema
Ehrhardt Proksch1, Regina Fölster-Holst, Jens-Michael Jensen
1Department of Dermatology, University of Kiel, Schittenhelmstr. 7, 24105 Kiel, Germany. eproksch@dermatology.uni-kiel.de
Journal of Dermatological Science
|August 5, 2006
Summary
Skin barrier impairment is central to eczema, including atopic dermatitis (AD). Treatments focus on restoring this barrier to normalize skin function and reduce inflammation.
Area of Science:
- Dermatology
- Immunology
- Genetics
Background:
- Skin permeability barrier function is compromised in eczema, especially atopic dermatitis (AD).
- In contact dermatitis, barrier disruption precedes inflammation and sensitization.
- Atopic dermatitis exhibits a genetically determined impaired skin barrier in both lesional and non-lesional skin.
Purpose of the Study:
- To elucidate the role of skin barrier dysfunction in the pathogenesis of eczema and atopic dermatitis.
- To understand the mechanisms leading to impaired barrier function in AD.
- To highlight the connection between barrier defects and the broader atopic syndrome.
Main Methods:
- Review of existing literature on skin barrier function in eczema and AD.
- Analysis of the interplay between epidermal proliferation, differentiation, and lipid composition.
- Examination of the immunological consequences of barrier defects.
Main Results:
- Impaired skin barrier function is a key feature in both contact dermatitis and atopic dermatitis.
- Genetic factors contribute significantly to barrier defects in AD.
- Barrier dysfunction facilitates allergen penetration, triggering immune responses and inflammation.
Conclusions:
- Barrier dysfunction is critically involved in the pathogenesis of atopic dermatitis.
- The atopic syndrome encompasses barrier defects across multiple mucosal surfaces, contributing to allergic diseases.
- Restoring the skin barrier with lipid-based emollients is a primary treatment strategy for eczema.